What is the fair value of Quanterix Corp (NASDAQ-QTRX) stock?

The current fair value estimate for Quanterix Corp (NASDAQ-QTRX) is $5.75. This implies an estimated upside of 42.4% versus the current market price.

Is Quanterix Corp (NASDAQ-QTRX) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 42.4% versus the current market price.

What is the analyst price target for NASDAQ-QTRX stock?

The available analyst price target for Quanterix Corp (NASDAQ-QTRX) is $4.33. The analyst target implies estimated upside of 7.3%.

How is the financial health of Quanterix Corp?

The current financial health read for Quanterix Corp (NASDAQ-QTRX) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Quanterix Corp's next earnings date?

The next earnings date currently listed for Quanterix Corp (NASDAQ-QTRX) is August 10, 2026.

Does Quanterix Corp (NASDAQ-QTRX) pay dividends?

Based on the current data, dividend yield is 0.0%.

What is the P/E ratio for Quanterix Corp (NASDAQ-QTRX)?

The current P/E ratio listed for Quanterix Corp (NASDAQ-QTRX) is -1.8x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Quanterix Corp?

The current market capitalization listed for Quanterix Corp is 183.7 M.

What is the enterprise value of Quanterix Corp?

The current enterprise value listed for Quanterix Corp is 126.9 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Quanterix Corp?

The ticker symbol for Quanterix Corp is NASDAQ-QTRX, and the stock is listed on NASDAQ.

Where is Quanterix Corp (NASDAQ-QTRX) listed?

Quanterix Corp (NASDAQ-QTRX) is listed on NASDAQ.

What is the debt-to-total-capital ratio for Quanterix Corp?

The current debt-to-total-capital ratio listed for Quanterix Corp is 16.1%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Quanterix Corp?

The free float listed for Quanterix Corp is 81.6%. Free float helps investors understand how much of the share base is available for public trading.

Quanterix Corp (QTRX) Fair Value & Stock Analysis

Quanterix Corp (QTRX)

Quanterix Corp. is a life sciences company listed on NASDAQ under the ticker QTRX. The company develops and commercializes protein-detection instruments and related consumables for research and clinical applications. Its platform includes the HD-X instrument for protein detection, the SR-X instrument for expanded Simoa-based research use, and the SP-X instrument, which uses Simoa planar array technology for multiplex chemiluminescent immunoassays. Quanterix also supplies assays, reagents, antibodies, replacement parts, and other components used in enzyme-based immunoassay workflows.

In addition to its product portfolio, the company provides contract research and clinical laboratory testing services, including research testing, clinical trial testing, and lucent diagnostic services. Its solutions are used across neurology, oncology, immunology, and inflammation research, with customers primarily drawn from academic and government laboratories, as well as pharmaceutical, biotechnology, and contract research organizations. Founded in 2007 and headquartered in Billerica, Massachusetts, the company operates across North America, Europe, the Middle East, Africa, and the Asia Pacific region.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Technical Outlook FAQ

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Upcoming Dividend Ex-Date	Dividend Payment Date	Upcoming Dividend	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Payout Ratio	Free Cash Flow / Net Income
NASDAQ-QTRX	$5.75	42.4% Upside	Undervalued	$4.33	7.3% Upside	Fair	Fair	—	—	—	0.0%	August 10, 2026	-1.8x	0.7x	1.3x	183.7 M	126.9 M	16.1%	81.6%	-2.1	—	79.6%